Intravenous treatment of fibromyalgia with the 5-HT3 receptor antagonist tropisetron in a rheumatological practice

Scandinavian Journal of Rheumatology, Supplement

Volumn 33, Issue 119, 2004, Pages 72-75

  Tolk, J ^a,d   Kohnen, R ^b   Muller W ^c  

^a Rheumatology Practice   (Germany)

^b IMEREM Inst Med Res Mgmt B   (Germany)

^c Hochrhein Inst fur Rehab Forsch   (Germany)

^d Arzt F Innere Medizin/Rheumatologe   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN ANTAGONIST; TROPISETRON; INDOLE DERIVATIVE; SEROTONIN 3 RECEPTOR;

ADULT; CONFERENCE PAPER; CONSTIPATION; CONTROLLED STUDY; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERANCE; FATIGUE; FEMALE; FIBROMYALGIA; FOLLOW UP; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PAIN ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOLOGY; SLEEP; TREATMENT OUTCOME; ARTICLE; DRUG ANTAGONISM; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PAIN; RETROSPECTIVE STUDY;

FEMALE; FIBROMYALGIA; HUMANS; INDOLES; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PAIN; QUESTIONNAIRES; RECEPTORS, SEROTONIN, 5-HT3; RETROSPECTIVE STUDIES; RHEUMATOLOGY; SEROTONIN ANTAGONISTS;

EID: 4444293480     PISSN: 03013847     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009740410007104     Document Type: Conference Paper

References (9)

1. Forseth KO, Gran JT. Management of fibromyalgia. What are the best treatment choices? Drug 2002;62:577-92.
2. Miller LJ, Kubes KL. Serotonic agents in the treatment of fibromyalgia syndrome. Ann Pharmacotherapy 2002;36:707-12.
3. Muller W. Neue Aspekte in der medikamentösen Behandlung der Fibromyalgie. In: Moorahrend U (ed.). Problemdiagnose 'Fibromyalgie' 1997;93-100.
4. Mease PJ, Crofford LJ, Russell IJ, Young JP, Sharma U, Knapp L. Pregabalin improves pain, sleep, and fatigue associated with fibromyalgia syndrome (FMS) in a multicenter, randomized, placebo-controlled, monotherapy trial. Ann Rheum Dis 2003;Suppl 1:77.
5. Müller W, Stratz T, Schochat T, Mennet P. Therapy of fibromyalgia by 5-HT3 antagonists. Z Rheumatol 1994; 53 Suppl 1:24.
6. Stratz T, Schochat T, Hrycaj P, Lacki J, Mennet P, Farber L, et al. Therapy of generalized tendomyopathy (fibromyalgia) caused by blocking 5-HT3 receptors. Z Rheumatol 1994;53:225-38.
7. 3-receptor antagonist. Scand J Rheumatol 2000; 29 Suppl 113:49-54.
8. Stratz T, Varga B, Muller W. The influence of depression on the effect of Tropisetron in the therapy of fibromyalgia. Z Rheumatol 2002;61:1-4.
9. Spath M, Stratz T, Neeck G, Kotter I, Hammel B, Amberger CC, et al. Efficacy and tolerability of IV tropisetron in the treatment of fibromyalgia. Scand J Rheumatol 2004 (in press).